Biomea Fusion (BMEA) announced that it has commenced an underwritten public offering of shares of its common stock and accompanying warrants to purchase shares of its common stock and, in lieu of common stock to certain investors, pre-funded warrants to purchase shares of its common stock and accompanying warrants to purchase shares of its common stock. All of the shares, pre-funded warrants and accompanying common stock warrants to be sold in the proposed offering are to be sold by Biomea. The offering is expected to close on or about June 20, subject to the satisfaction of customary closing conditions. Jefferies is acting as sole book running manager for the proposed offering.
Confident Investing Starts Here:
- Easily unpack a company's performance with TipRanks' new KPI Data for smart investment decisions
- Receive undervalued, market resilient stocks right to your inbox with TipRanks' Smart Value Newsletter
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on BMEA:
- Biomea Fusion Stockholders Vote on Key Proposals
- Promising Phase 1 Results and Strategic Focus Drive Buy Rating for Biomea Fusion
- Largest borrow rate increases among liquid names
- Biomea Fusion reports data from Phase I COVALENT-103 trial of BMF-500
- Biomea Fusion assumed with an Overweight at Piper Sandler
Looking for a trading platform? Check out TipRanks' Best Online Brokers guide, and find the ideal broker for your trades.
Report an Issue